Mirati Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Mirati Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q3 2023.
  • Mirati Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 70.1M shares, a 21.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 70.1M +12.5M +21.8% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 58.3M +2.75M +4.94% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 58.1M +2.64M +4.75% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 57.9M +2.5M +4.51% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 57.6M +5.8M +11.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 55.6M +3.98M +7.72% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 55.5M +4.14M +8.05% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 55.4M +4.92M +9.75% Dec 31, 2021 10-K 2023-02-28
Q3 2021 51.8M +7.28M +16.4% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 51.6M +7.13M +16% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 51.4M +7.82M +18% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 50.4M +10.9M +27.6% Dec 31, 2020 10-K 2022-02-28
Q3 2020 44.5M +5.11M +13% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 44.5M +5.93M +15.4% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 43.6M +7.52M +20.9% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 39.5M +6.98M +21.4% Dec 31, 2019 10-K 2021-02-25
Q3 2019 39.4M +6.85M +21.1% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 38.6M +6.24M +19.3% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 36M +7M +24.1% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 32.5M +3.92M +13.7% Dec 31, 2018 10-K 2020-02-26
Q3 2018 32.5M +7.54M +30.2% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 32.3M +7.34M +29.4% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 29M +4.09M +16.4% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 28.6M +8.69M +43.6% Dec 31, 2017 10-K 2019-02-28
Q3 2017 25M +5.05M +25.4% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 25M +5.05M +25.3% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 24.9M +5.03M +25.3% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 19.9M +654K +3.39% Dec 31, 2016 10-K 2018-03-08
Q3 2016 19.9M +658K +3.42% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 19.9M +3.58M +21.9% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 19.9M +3.72M +23% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 19.3M +5.72M +42.1% Dec 31, 2015 10-K 2017-03-09
Q3 2015 19.3M +5.74M +42.5% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 16.3M +2.83M +20.9% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 16.2M +2.74M +20.3% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 13.6M +120K +0.89% Dec 31, 2014 10-K 2016-03-09
Q3 2014 13.5M +3.56M +35.8% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 13.5M +3.57M +35.8% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 13.4M Mar 31, 2014 10-Q 2014-05-15
Q4 2013 13.4M +3.49M +35% Dec 31, 2013 10-K 2015-03-11
Q3 2013 9.96M Sep 30, 2013 10-Q 2013-11-12
Q2 2013 9.96M Jun 30, 2013 10-Q 2013-08-13
Q4 2012 9.96M Dec 31, 2012 10-K 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.